103 related articles for article (PubMed ID: 21369703)
1. Monitoring peri-operative immune suppression in renal cancer patients.
Hase S; Weinitschke K; Fischer K; Fornara P; Hoda R; Unverzagt S; Seliger B; Riemann D
Oncol Rep; 2011 May; 25(5):1455-64. PubMed ID: 21369703
[TBL] [Abstract][Full Text] [Related]
2. Immunological stress in kidney cancer patients undergoing either open nephrectomy or nephron-sparing surgery: an immunophenotypic study of lymphocyte subpopulations and circulating dendritic cells.
Porta C; Bonomi L; Lillaz B; Klersy C; Imarisio I; Paglino C; Rovati B; Danova M; Ferraris E; Mensi M; Rovereto B
Oncol Rep; 2008 Dec; 20(6):1511-9. PubMed ID: 19020735
[TBL] [Abstract][Full Text] [Related]
3. Renal cell carcinoma-induced immunosuppression: an immunophenotypic study of lymphocyte subpopulations and circulating dendritic cells.
Porta C; Bonomi L; Lillaz B; Paglino C; Rovati B; Imarisio I; Morbini P; Villa C; Danova M; Mensi M; Rovereto B
Anticancer Res; 2007; 27(1A):165-73. PubMed ID: 17352228
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.
Brasanac D; Marković-Lipkovski J; Hadzi-Djokić J; Müller GA; Müller CA
Neoplasma; 1999; 46(3):173-8. PubMed ID: 10613593
[TBL] [Abstract][Full Text] [Related]
5. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
6. An assessment of lymphocytic population in peripheral blood of patients with renal cell carcinoma before and after embolization.
Osada J; Pietruczuk M; Dabrowska M; Kordecki K; Janica J; Walecki J
Rocz Akad Med Bialymst; 2000; 45():228-39. PubMed ID: 11712434
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma.
Romero JM; Aptsiauri N; Vazquez F; Cozar JM; Canton J; Cabrera T; Tallada M; Garrido F; Ruiz-Cabello F
Tissue Antigens; 2006 Oct; 68(4):303-10. PubMed ID: 17026465
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T cells, dendritic cells and neutrophils in patients with renal cell carcinoma.
Minárik I; Lašťovička J; Budinský V; Kayserová J; Spíšek R; Jarolím L; Fialová A; Babjuk M; Bartůňková J
Immunol Lett; 2013 May; 152(2):144-50. PubMed ID: 23721909
[TBL] [Abstract][Full Text] [Related]
9. HLA class I antigens expression in renal cell carcinoma: histopathological and clinical correlation.
Brasanac D; Müller CA; Müller GA; Hadzi-Dzokic J; Markovic-Lipkovski J
J Exp Clin Cancer Res; 1999 Dec; 18(4):505-10. PubMed ID: 10746977
[TBL] [Abstract][Full Text] [Related]
10. [Monitoring of anti-tumour cell-mediated response in patients with renal cell carcinoma, disturbance of T cell proliferation].
Lukesová S; Vroblová V; Hlávková D; Kopecký O; Vokurková D; Morávek P; Safránek H; Soucek P
Vnitr Lek; 2008 Feb; 54(2):139-45. PubMed ID: 23687704
[TBL] [Abstract][Full Text] [Related]
11. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
[TBL] [Abstract][Full Text] [Related]
12. Complex perioperative immuno-dysfunction in patients with renal cell carcinoma.
Böhm M; Ittenson A; Philipp C; Röhl FW; Ansorge S; Allhoff EP
J Urol; 2001 Sep; 166(3):831-6. PubMed ID: 11490228
[TBL] [Abstract][Full Text] [Related]
13. Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccines.
Mulders P; Tso CL; Gitlitz B; Kaboo R; Hinkel A; Frand S; Kiertscher S; Roth MD; deKernion J; Figlin R; Belldegrun A
Clin Cancer Res; 1999 Feb; 5(2):445-54. PubMed ID: 10037196
[TBL] [Abstract][Full Text] [Related]
14. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma.
Bukur J; Rebmann V; Grosse-Wilde H; Luboldt H; Ruebben H; Drexler I; Sutter G; Huber C; Seliger B
Cancer Res; 2003 Jul; 63(14):4107-11. PubMed ID: 12874014
[TBL] [Abstract][Full Text] [Related]
15. Prospective comparison of the immunological and stress response following laparoscopic and open surgery for localized renal cell carcinoma.
Landman J; Olweny E; Sundaram CP; Chen C; Rehman J; Lee DI; Shalhav A; Portis A; McDougall EM; Clayman RV
J Urol; 2004 Apr; 171(4):1456-60. PubMed ID: 15017197
[TBL] [Abstract][Full Text] [Related]
16. [Effect of transcatheter renal arterial embolization combined with cryoablation on regulatory CD4+ CD25+ T lymphocytes in the peripheral blood of patients with advanced renal carcinoma].
Liu CF; Guo Z; Si TG; Xing WG; Liu F; Xing JZ
Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(13):902-5. PubMed ID: 20646510
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma--a report of ten cases].
Wang H; Zhou FJ; Wang QJ; Qin ZK; Huang LX; Liu ZW; Han H; Li YQ; Chen SP; Xia JC
Ai Zheng; 2006 May; 25(5):625-30. PubMed ID: 16687087
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant therapy of renal cell carcinoma patients with an autologous tumor cell lysate vaccine: a 5-year follow-up analysis.
Repmann R; Goldschmidt AJ; Richter A
Anticancer Res; 2003; 23(2A):969-74. PubMed ID: 12820332
[TBL] [Abstract][Full Text] [Related]
19. Structure, expression and function of HLA-G in renal cell carcinoma.
Seliger B; Schlaf G
Semin Cancer Biol; 2007 Dec; 17(6):444-50. PubMed ID: 17707652
[TBL] [Abstract][Full Text] [Related]
20. Changes in the expression of surface receptors on lymphocyte subsets in the elderly: quantitative flow cytometric analysis.
Ginaldi L; De Martinis M; D'Ostilio A; Marini L; Loreto F; Modesti M; Quaglino D
Am J Hematol; 2001 Jun; 67(2):63-72. PubMed ID: 11343377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
